UK Suspends Novartis Corporation Drug Prexige on Liver Fears

LONDON, Nov 19 (Reuters) - Britain’s Medicines and Healthcare products Regulatory Agency said on Monday it had suspended the licence on Novartis AG’s painkiller Prexige due to safety concerns about possible liver damage.

MORE ON THIS TOPIC